↓ Skip to main content

Cochrane Database of Systematic Reviews

Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia

Overview of attention for article published in Cochrane database of systematic reviews, November 2012
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
6 tweeters

Citations

dimensions_citation
53 Dimensions

Readers on

mendeley
166 Mendeley
Title
Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia
Published in
Cochrane database of systematic reviews, November 2012
DOI 10.1002/14651858.cd008079.pub2
Pubmed ID
Authors

Kathrin Bauer, Michaela Rancea, Verena Roloff, Thomas Elter, Michael Hallek, Andreas Engert, Nicole Skoetz

Abstract

Chronic lymphocytic leukaemia (CLL) accounts for 25% of all leukaemias and is the most common lymphoid malignancy in western countries. Standard treatments include mono- or polychemotherapies, usually combined with monoclonal antibodies such as rituximab or alemtuzumab. However, the impact of these agents remains unclear, as there are hints for increased risk of severe infections.

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 166 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 2 1%
Colombia 1 <1%
France 1 <1%
Brazil 1 <1%
Russia 1 <1%
Croatia 1 <1%
Unknown 159 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 23 14%
Researcher 22 13%
Student > Bachelor 20 12%
Other 16 10%
Student > Ph. D. Student 16 10%
Other 31 19%
Unknown 38 23%
Readers by discipline Count As %
Medicine and Dentistry 79 48%
Agricultural and Biological Sciences 8 5%
Nursing and Health Professions 8 5%
Biochemistry, Genetics and Molecular Biology 8 5%
Pharmacology, Toxicology and Pharmaceutical Science 6 4%
Other 18 11%
Unknown 39 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 April 2013.
All research outputs
#6,673,671
of 22,685,926 outputs
Outputs from Cochrane database of systematic reviews
#8,381
of 12,300 outputs
Outputs of similar age
#50,009
of 179,003 outputs
Outputs of similar age from Cochrane database of systematic reviews
#163
of 236 outputs
Altmetric has tracked 22,685,926 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 12,300 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.3. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 179,003 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 236 others from the same source and published within six weeks on either side of this one. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.